MedPath
NMPA Approval

Mumps Vaccine,Live

国药准字S10840001

April 26, 2020

Drug Information

腮腺炎减毒活疫苗

注射剂

复溶后每瓶0.5ml。每1次人用剂量0.5ml,含腮腺炎活病毒应不低于3.7lgCCID50。

生物制品

April 26, 2020

Company Information

Applicant Company

上海市长宁区延安西路1262号

Manufacturing Company

上海市奉贤区广丰路758号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

腮腺炎减毒活疫苗 - NMPA 批准文号 | MedPath